See if You Qualify
Fill out the form below to see if you meet the basic study requirements. Your personal information will only be used for the purposes of the study.
Frequently asked questions
Yes, the study requires that you have a diagnosis of bipolar disorder and have tried a medication for bipolar disorder in the past 5 years. You do not need to be taking medication currently or be under psychiatric care currently to qualify.
NRX-101 is a capsule that combines two medications that are already FDA-approved for other uses. The medications are D-cycloserine and lurasidone HCI (commonly used to treat bipolar disorder).
There is no placebo group in this study but there is a control group. The control group will receive only lurasidone, instead of the study drug NRX-101 which combines lurasidone and D-cycloserine.
All study-related care is provided at no cost and travel is reimbursed.
The length of study participation is approximately 10 weeks.
Yes, there is compensation available for participation and travel. Compensation amounts are determined on a site-by-site basis. Please check with your site for more information.
Yes, participation is completely voluntary and can be ended at any time.